EP1311239A4 - Oral delivery of peptide - Google Patents
Oral delivery of peptideInfo
- Publication number
- EP1311239A4 EP1311239A4 EP00952034A EP00952034A EP1311239A4 EP 1311239 A4 EP1311239 A4 EP 1311239A4 EP 00952034 A EP00952034 A EP 00952034A EP 00952034 A EP00952034 A EP 00952034A EP 1311239 A4 EP1311239 A4 EP 1311239A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- peptide
- oral delivery
- oral
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2000/000892 WO2002013782A1 (en) | 2000-08-11 | 2000-08-11 | Oral delivery of peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1311239A1 EP1311239A1 (en) | 2003-05-21 |
EP1311239A4 true EP1311239A4 (en) | 2005-06-22 |
Family
ID=19198254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00952034A Withdrawn EP1311239A4 (en) | 2000-08-11 | 2000-08-11 | Oral delivery of peptide |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1311239A4 (en) |
JP (1) | JP2004506003A (en) |
CN (1) | CN1479609A (en) |
AU (1) | AU2000264796A1 (en) |
CA (1) | CA2420032A1 (en) |
WO (1) | WO2002013782A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6761901B1 (en) * | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
US8658202B2 (en) | 2001-04-25 | 2014-02-25 | Western University Of Health Sciences | Coated drug delivery formulations |
US6759058B1 (en) * | 2001-04-25 | 2004-07-06 | Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences | Enteric-coated proliposomal formulations for poorly water soluble drugs |
WO2003059288A2 (en) | 2002-01-09 | 2003-07-24 | Enzrel, Inc. | Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
CN100371018C (en) * | 2003-06-12 | 2008-02-27 | 刘青松 | Calcitonin composition |
JP4669665B2 (en) * | 2004-04-12 | 2011-04-13 | 正彦 阿部 | Polycation-modified liposome having no cytotoxicity and method for producing the same |
WO2006062506A1 (en) * | 2004-12-03 | 2006-06-15 | Enzrel, Inc. | Chitosan-coated liposome drug delivery of antioxidant or anti-inflammatory compounds |
JP2008179563A (en) * | 2007-01-24 | 2008-08-07 | Cosmo Shokuhin Kk | Functional material and functional food comprising useful phospholipid composition |
WO2009149537A1 (en) * | 2008-06-12 | 2009-12-17 | Christine Allen | Injectable polymer-lipid blend |
AU2010260211B2 (en) | 2008-12-22 | 2016-04-21 | Acerus Pharmaceuticals USA, LLC | Safe desmopressin administration |
CN103127003B (en) * | 2013-03-19 | 2014-05-07 | 广东彼迪药业有限公司 | Omeprazole enteric micropelets and capsule as well as preparation method thereof |
CN105902400B (en) * | 2016-06-17 | 2019-10-11 | 四川百奥可生物科技有限责任公司 | A kind of particle and its preparation method and application of wrapping biological enzyme |
CN114010801B (en) * | 2021-11-16 | 2023-09-26 | 上海理工大学 | L-ascorbyl palmitate modified small molecule peptide liposome and preparation and application thereof |
CN114081963B (en) * | 2021-11-16 | 2023-09-26 | 上海理工大学 | Nanometer carrier for improving bioavailability of active peptide and preparation and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4615885A (en) * | 1983-11-01 | 1986-10-07 | Terumo Kabushiki Kaisha | Pharmaceutical composition containing urokinase |
EP0855179A2 (en) * | 1997-01-16 | 1998-07-29 | Lipotec, S.A. | Pharmaceutical preparation comprising coated capsules or tablets containing a liposome powder encapsulating a drug |
-
2000
- 2000-08-11 AU AU2000264796A patent/AU2000264796A1/en not_active Abandoned
- 2000-08-11 JP JP2002518929A patent/JP2004506003A/en active Pending
- 2000-08-11 EP EP00952034A patent/EP1311239A4/en not_active Withdrawn
- 2000-08-11 CA CA002420032A patent/CA2420032A1/en not_active Abandoned
- 2000-08-11 CN CNA008198144A patent/CN1479609A/en active Pending
- 2000-08-11 WO PCT/KR2000/000892 patent/WO2002013782A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4615885A (en) * | 1983-11-01 | 1986-10-07 | Terumo Kabushiki Kaisha | Pharmaceutical composition containing urokinase |
EP0855179A2 (en) * | 1997-01-16 | 1998-07-29 | Lipotec, S.A. | Pharmaceutical preparation comprising coated capsules or tablets containing a liposome powder encapsulating a drug |
Non-Patent Citations (1)
Title |
---|
See also references of WO0213782A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2420032A1 (en) | 2002-02-21 |
AU2000264796A1 (en) | 2002-02-25 |
JP2004506003A (en) | 2004-02-26 |
WO2002013782A1 (en) | 2002-02-21 |
CN1479609A (en) | 2004-03-03 |
EP1311239A1 (en) | 2003-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1383518A4 (en) | Oral delivery of macromolecules | |
EG23943A (en) | Flash-melt oral dosage formulation | |
HUP0203204A3 (en) | Oral dosage forms | |
PL367180A1 (en) | Stabilized oral pharmaceutical composition | |
MXPA03004941A (en) | Drug formulation having improved oral tolerability. | |
PL364621A1 (en) | Nicotine-containing oral dosage form | |
EP1585503A4 (en) | Improved oral delivery of peptides | |
EP1311239A4 (en) | Oral delivery of peptide | |
GB2383989B (en) | Improved oral medicine dispenser | |
HUP0500638A3 (en) | Flashmelt oral dosage formulation | |
SI1462455T1 (en) | Ser-Ser-Ser-Arg peptide and medicinal uses thereof | |
AP2003002783A0 (en) | Medicament containing activted antihtrombin iii | |
HUP0201667A3 (en) | Oral form of administration | |
IL147731A0 (en) | Peptide pharmaceutical formulations | |
AU2002239279A1 (en) | Oral nanosphere delivery | |
EP1275657A4 (en) | Peptide derivatives and medicinal compositions | |
IL135442A0 (en) | Peptides and pharmaceutical compositions comprising them | |
GB2361643B (en) | Delivery capsules | |
PL362244A1 (en) | Medicinal compositions | |
GB0021645D0 (en) | Delivery of substances | |
EP1230928A4 (en) | Use of peptide | |
HK1047232A1 (en) | Oral dosage forms | |
IL136274A0 (en) | Pharmaceutical compositions comprising vip-related peptides | |
IL138971A0 (en) | Pharmaceutical compositions comprising vip-related peptides | |
GB0021927D0 (en) | Use of pharmaceutical combination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030211 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RBV | Designated contracting states (corrected) |
Designated state(s): BE DE ES FR GB IT |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050506 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 9/28 B Ipc: 7A 61K 9/20 B Ipc: 7A 61K 9/127 A |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060301 |